ClinicalTrials.gg
RecruitingNCT07139821Updated Apr 29, 2026

Dietary Iron Requirements

An interventional study of Stable iron isotope in Iron Absorption, sponsored by Pennington Biomedical Research Center. Recruiting at 2 sites in United States. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-29.

Sponsored by Pennington Biomedical Research Center · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Not applicable
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 82 studies in Iron Deficiencies with a site in United States — 16 open to participants now, 20 under way, 4 of them phase 3. Iron Deficiencies · United States.

Planned enrollment
6th of 63
300 · median 89
Started
2026
with 7 others
No phase
29 of 82
6 open now
Primary completion
2028-08
later than 16 of 19 live
Registered
71st of 82
by date
Lead sponsor
2 of 82
Pennington Biomedical Research Center

Among the 82 studies in Iron Deficiencies with a site in United States, this one is the 6th largest by planned enrollment of the 63 interventional ones that give a count, is one of 8 that started in 2026, is one of 29 with no phase, reaches primary completion later than 16 of the 19 other live ones, and was the 71st registered.

Iron Deficiencies

386 studies on the registry are indexed under Iron Deficiencies; 78 are open to participants now.

Browse Iron Deficiencies studies →

Open to participants now

16 of the 82 studies in Iron Deficiencies with a site in United States are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 53 Iron Deficiencies studies recruiting now, 23 (43%) set no upper age limit and 26 (49%) stop at 75 or younger; 14 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 82 studies in Iron Deficiencies with a site in United States, or all of them as a file.
02

Study summary

Dietary Reference Intakes (DRIs) for iron are based on a relatively small number of studies in European populations. This research study will determine iron needs in a representative sample of adults living in the US using the iron isotope dilution technique. Following administration and equilibration of a stable iron isotope, participants will be followed for a 12 week study period. Blood will be collected every 4 weeks and the isotopic composition will be determined. Results will help update dietary iron guidelines making sure they better match the specific needs of the US population.

03

Conditions studied

  • Iron Absorption

Keywords

  • Iron absorption
  • Iron losses
  • Iron requirements
  • Iron deficiency
  • Iron deficiency anemia
  • Iron isotopes
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Males and premenopausal females age 18-50 y
  • Previously participated in an iron stable isotope study or willing to consume an oral stable iron isotope and undergo a one-year equilibration period
  • Willing to refrain from iron-containing supplements for the duration of the study
  • Willing to refrain from tobacco smoking for the duration of the study
  • Have not donated blood 3 months prior to the start of the study and willing to refrain from donating blood for the duration of the study
  • Willing to have blood stored for future use
  • Able and willing to comply with study requirements and consent to participate

Exclusion criteria

Exclusion Criteria:

  • Females: pregnant or lactating or plans to become pregnant during the study period
  • Inability to provide and engage in informed consent procedures
  • Plans to relocate outside the study area
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    US males and premenopausal females

    A representative sample of adult males and premenopausal females living in the US

    Other: Stable iron isotope

Interventions

  • OtherStable iron isotope

    Stable iron isotopes will be used to determine iron requirements.

06

What researchers measure

Primary outcomes

  1. Iron isotope composition in blood

    Tracer-to-tracee rate in venous blood samples collected at multiple time points

    Time frame: 12 weeks

07

Study locations

2 of 2 sites recruiting
  • LSU Pennington Biomedical Research Center
    Baton Rouge, Louisiana 70808, United States
    Recruiting
  • Cornell University
    Ithaca, New York 14853, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Aug 2028, 29 months after the start.

Of 77 non-industry interventional studies with no phase under Iron Deficiencies, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 29 months is above that.

Counting every sponsor, half of 89 studies reached it within 10 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 7, 2025
First posted
Aug 24, 2025
StartActual
Feb 6, 2026
Primary completionEst.
Aug 1, 2028
CompletionEst.
May 31, 2029
Last update
Apr 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07139821
Collaborators
Cornell University
Responsible party
Sponsor
First posted
Aug 24, 2025
Start date
Feb 6, 2026
Primary completion
Aug 1, 2028 (estimated)
Completion
May 31, 2029 (estimated)
Last update
Apr 29, 2026

Study contacts

Stephen Hennigar, PhD
Contact
stephen.hennigar@pbrc.edu
225-763-2612

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion